tiprankstipranks
Trending News
More News >
Embecta Corporation (EMBC)
NASDAQ:EMBC
US Market
Advertisement

Embecta Corporation (EMBC) Similar Stocks

Compare
92 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Embecta Corporation
$14.38
$808.85M
9.67
5.81%
1 Buy
2 Hold
1 Sell
Hold
Dynavax
$10.50
$1.23B
64.45
-7.89%
3 Buy
0 Hold
1 Sell
Moderate Buy
Avadel Pharmaceuticals
$15.24
$1.48B
-7.64%
8 Buy
1 Hold
0 Sell
Strong Buy
Supernus Pharmaceuticals
$44.88
$2.52B
39.22
28.34%
2 Buy
2 Hold
0 Sell
Moderate Buy
ANI Pharmaceuticals
$91.01
$1.98B
47.55%
6 Buy
2 Hold
0 Sell
Strong Buy
Harrow Health
$39.12
$1.45B
-8.38%
7 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
EMBC
Embecta Corporation
14.38
0.79
5.81%
DVAX
Dynavax
10.50
-0.90
-7.89%
AVDL
Avadel Pharmaceuticals
15.24
-1.22
-7.41%
SUPN
Supernus Pharmaceuticals
44.88
10.01
28.71%
ANIP
ANI Pharmaceuticals
91.01
27.72
43.80%
HROW
Harrow Health
39.12
-5.10
-11.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis